Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults

Overview of attention for article published in BMC Infectious Diseases, April 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 48 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 25,019 followers.

@nicd_sa https://t.co/D5twxvzMgY

20 Apr 2020

Reply Repost Favourite

New assessment of an optimized manufacturing process for inactivated quadrivalent #influenza vaccine, https://t.co/6F9fUef4Bs w/ @GSK @HMHOSPITALES @IHPpediatria @GENVIP_RESEARCH @clf_citec @PediatresAfpa @pfizer https://t.co/IZB1R8CfJz

01 May 2018

Reply Repost Favourite

Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults https://t.co/33QmUyxpCq #bmcinfectdis

23 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.